Biotechgate Announces Collaboration with PharmaTell to Deliver Cutting-Edge Analyst Reports

ZURICH, Switzerland, May 2024 – Biotechgate, a leading provider of life sciences information and partnering solutions, is delighted to announce its strategic collaboration with PharmaTell, a respected provider of high-quality analyst reports covering the entire healthcare industry. This partnership aims to enhance the new version of the Biotechgate database by implementing PharmaTell’s analyst reports, providing users with unrivalled market intelligence and strategic insights.

The inclusion of PharmaTell’s reports is one of several features integrated into the new version of the Biotechgate database, including information on mergers and acquisitions, improved asset and clinical trial linking, as well as a host of usability improvements that enable it to be a comprehensive database, allowing users to make informed decisions.

“We are excited to collaborate with PharmaTell and integrate their renowned analyst reports into Biotechgate. It’s a tool we have been using already for our valuation services,” stated Patrik Frei, CEO of Venture Valuation / Biotechgate. “This partnership underscores our commitment to provide our users with a one-stop-shop for life sciences industry intelligence, including non-public information on financing, clinical trials, licensing deal terms, company information and more.”

Founded in 2003, PharmaTell’s analyst reports cover a wide breadth of intelligence from the global market to product-specific clinical data. With over 200,000 reports available from 50 leading stockbrokers, their analyst reports enable individuals working in the life sciences industry to stay ahead of the curve with up-to-date sector intelligence and tools for benchmarking.

Speaking about the collaboration, PharmaTell Managing Director, Janno Roele, said, “We are thrilled to partner with Biotechgate to make our analyst reports more accessible to industry professionals worldwide. By leveraging Biotechgate’s robust platform, we can reach a broader audience and provide valuable intelligence to support their business objectives.”

The new release of Biotechgate, featuring a dedicated Analyst Reports section, is set to enhance the industry intelligence and decision-making of life science professionals worldwide. If you wish to try a demo or a complimentary trial, visit

About Biotechgate:

Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 60,000 life science company profiles. Thanks to its unique data-sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds and management details, making it an invaluable resource for life sciences start-ups, pharma companies, investors, and other industry professionals. Biotechgate also features 35,000 licensing deals and a clinical trials database containing over 900,000 records from registries around the world.

About PharmaTell:

PharmaTell was founded in 2003 and is since then completely dedicated to making Equity Research available for the life sciences industry. Its global network of healthcare specialists collects, analyzes, and curates the latest financial equity research and reports to provide up-to-date insights on companies, products, and sectors. Its proprietary PharmaTell Studio database contains over 200,000 curated research reports covering the global healthcare sector.